Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 4
2015 1
2016 3
2018 1
2019 2
2020 1
2021 5
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Cannabinoids and Chronic Liver Diseases.
Mboumba Bouassa RS, Sebastiani G, Di Marzo V, Jenabian MA, Costiniuk CT. Mboumba Bouassa RS, et al. Int J Mol Sci. 2022 Aug 20;23(16):9423. doi: 10.3390/ijms23169423. Int J Mol Sci. 2022. PMID: 36012687 Free PMC article. Review.
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial.
Mboumba Bouassa RS, Comeau E, Alexandrova Y, Pagliuzza A, Yero A, Samarani S, Needham J, Singer J, Lee T, Bobeuf F, Vertzagias C, Sebastiani G, Margolese S, Mandarino E, Klein MB, Lebouché B, Routy JP, Chomont N, Costiniuk CT, Jenabian MA. Mboumba Bouassa RS, et al. Cells. 2023 Jul 8;12(14):1811. doi: 10.3390/cells12141811. Cells. 2023. PMID: 37508476 Free PMC article.
To assess the effects of oral cannabinoids during HIV, ten PWH on ART were randomized (n = 5/group) to increasing doses of oral delta9-tetrahydrocannabinol (THC): cannabidiol (CBD) combination (2.5:2.5-15:15 mg/day) capsules or CBD-only (200-800 mg/day) capsules for 12 wee …
To assess the effects of oral cannabinoids during HIV, ten PWH on ART were randomized (n = 5/group) to increasing doses of oral delta …
FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation.
Yero A, Shi T, Routy JP, Tremblay C, Durand M, Costiniuk CT, Jenabian MA. Yero A, et al. Front Immunol. 2022 Jul 29;13:962912. doi: 10.3389/fimmu.2022.962912. eCollection 2022. Front Immunol. 2022. PMID: 35967314 Free PMC article.
METHODS: Subsets of FoxP3(+) CD8 T-cells were characterized both prospectively and cross-sectionally in PBMCs from untreated acute (n=26) and chronic (n=10) HIV-infected individuals, early ART-treated in acute infection (n=10, median of ART initiation: 5.5 mo …
METHODS: Subsets of FoxP3(+) CD8 T-cells were characterized both prospectively and cross-sectionally in PBMCs from untreated acute (n …
Antiretroviral therapy-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.
Rothan C, Yero A, Shi T, Farnos O, Chartrand-Lefebvre C, El-Far M, Costiniuk CT, Tsoukas C, Tremblay C, Durand M, Jenabian MA; Canadian HIV and Aging Cohort Study. Rothan C, et al. AIDS. 2021 Jun 1;35(7):1003-1014. doi: 10.1097/QAD.0000000000002842. AIDS. 2021. PMID: 33587446
METHODS: Blood specimens were obtained from 142 participants including ART-treated HIV-infected adults with (n = 43) or without CAD (n = 41), as well as HIV-uninfected controls with (n = 31) or without CAD (n = 27). ...
METHODS: Blood specimens were obtained from 142 participants including ART-treated HIV-infected adults with (n = 43) or without CAD ( …
Association Between the Development of Subclinical Cardiovascular Disease and Human Immunodeficiency Virus (HIV) Reservoir Markers in People With HIV on Suppressive Antiretroviral Therapy.
Turcotte I, El-Far M, Sadouni M, Chartrand-Lefebvre C, Filali-Mouhim A, Fromentin R, Chamberland A, Jenabian MA, Baril JG, Trottier B, Thomas R, Tremblay CL, Durand M, Chomont N; Canadian HIV and Aging Cohort Study. Turcotte I, et al. Clin Infect Dis. 2023 Apr 3;76(7):1318-1321. doi: 10.1093/cid/ciac874. Clin Infect Dis. 2023. PMID: 36346439 Free PMC article.
Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy.
Meziane O, Alexandrova Y, Olivenstein R, Dupuy FP, Salahuddin S, Thomson E, Orlova M, Schurr E, Ancuta P, Durand M, Chomont N, Estaquier J, Bernard NF, Costiniuk CT, Jenabian MA. Meziane O, et al. J Immunol. 2021 Feb 1;206(3):641-651. doi: 10.4049/jimmunol.2000916. Epub 2020 Dec 14. J Immunol. 2021. PMID: 33318292
Bronchoalveolar lavage fluid and matched blood were obtained from asymptomatic ART-treated HIV(+) smokers (n = 11) and nonsmokers (n = 15) and uninfected smokers (n = 7) and nonsmokers (n = 10). ...
Bronchoalveolar lavage fluid and matched blood were obtained from asymptomatic ART-treated HIV(+) smokers (n = 11) and nonsmokers ( …
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.
Jenabian MA, Talla F, Talla P, Mbopi-Kéou FX, Charpentier C, Kane CT, Bélec L. Jenabian MA, et al. Niger Med J. 2015 Nov-Dec;56(6):420-4. doi: 10.4103/0300-1652.171613. Niger Med J. 2015. PMID: 26903701 Free PMC article.
RESULTS: Trugene HIV-1 Genotyping Assay() (Siemens Health Care Diagnostics, NY, USA) and ViroSeq HIV-1 Genotyping System()(Celera Diagnostics, CA, USA) assessed equivalently antiretroviral DRMs in P and RT genes from non-B HIV-1 Group M in 44 Cameroonian adults in virological fai …
RESULTS: Trugene HIV-1 Genotyping Assay() (Siemens Health Care Diagnostics, NY, USA) and ViroSeq HIV-1 Genotyping System()(Celera Diagnostic …
Clinical and Radiographic Evaluation of Chitosan Particles in Treatment of Intrabony Periodontal Defects: A Clinical Trial.
Faghani M, Jenabian N, Haghanifar S, Khafri S. Faghani M, et al. Front Dent. 2021 Jul 20;18:23. doi: 10.18502/fid.v18i23.6933. eCollection 2021. Front Dent. 2021. PMID: 35965715 Free PMC article.
Materials and Methods: In this clinical trial, 18 intrabony three-wall periodontal defects were randomly divided into three groups (n=6). The control group only received conventional flap surgery with a sulcular incision. ...
Materials and Methods: In this clinical trial, 18 intrabony three-wall periodontal defects were randomly divided into three groups (n …
Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic.
Fehr D, Lebouché B, Ruppenthal L, Brownc M, Obasc N, Bourbonnière E, Girouard J, Massicotte A, Jenabian MA, Almomen AA, Frenette C, de Pokomandy A, Cox J, Giannakis A, Cheng M, Kronfli N, Tsoukas C, Zahedi N, Szabo J, Dehghani K, Brouillette MJ, Falutz J, Turner H, Hamel A, Duchesneau C, Lanthier-Brun J, Klein M, Routy JP, Costiniuk CT. Fehr D, et al. AIDS Care. 2022 May;34(5):663-669. doi: 10.1080/09540121.2021.1904500. Epub 2021 Mar 28. AIDS Care. 2022. PMID: 33779425
Data on demographics, socioeconomic status, co-morbidities and severity of COVID-19 and outcomes were extracted. Of 1702 individuals, 32 (1.9%) had a positive COVID-19 test (n = 24) or symptoms suspicious for COVID-19 (n = 3). Median age was 52 years [IQR 40, 62]. . …
Data on demographics, socioeconomic status, co-morbidities and severity of COVID-19 and outcomes were extracted. Of 1702 individuals, 32 (1. …
27 results